Abstract:HCA-7 human colorectal cancer cells were transfected with miRNA precursor forms, pre-miR-143 or pre-miR-145; or c-Myc siRNA or scrambled oligonucleotides using Lipofectamine.Colon cancer cell or colonic fibroblast EGFR was activated with EGF or inhibited with C225 anti-EGFR antibodies.Western blotting was used to assess G1 cell cycle regulators: c-Myc, cdk6, cyclin D2, E2F3 and pRb.Northern blotting and real time PCR were used to measure miR-143 and miR-145.Cell proliferation and DNA synthesis were measured by WST-1 and BrdU incorporation, respectively.Results: Northern blotting confirmed low levels of miR-143 and miR-145 in human colon cancers and cell lines.As in the case of human cancers, miR-143 and miR-145 were down-regulated 90% in colonic tumors of mice with wt EGFR.In striking contrast, these miRNA were increased 4-5-fold in tumors from Wa2 Egfr mice.Wa2 mutations nearly abolish receptor kinase activity In Vitro.Up-regulations of pre-miR-143 or pre-miR-145 by transfection caused 60-70% reduction in proliferation and inhibited DNA synthesis by 80-90% in HCT116 cells, consistent with a tumor suppressor role for these miRNA.Modulating EGFR signals caused parallel changes in c-Myc, while inducing inverse changes in miR-143 and miR-145 in cancer cells (C225-treated) and fibroblasts (EGF-treated).c-Myc siRNA knock-down also increased miR-143 and miR-145 by 50-95% in cancer cells, while decreasing c-Myc ~90%, suggesting c-Myc mediates EGFR suppression of these miRNAs.Compared to control, EGF increased cdk6, pRb and E2F3, whereas C225 antibodies reduced these proteins in cancer cells, identifying these G1 regulators as EGFR targets.In contrast, pre-miR-143 and pre-miR-145 reduced these G1 regulators by 30-60% in HCT116 cells, suggesting they are also functional targets of miR-143 and miR-145.Conclusion: These studies suggest that EGFR proliferation is mediated by c-Myc via inhibition of miR-143 and miR-145.Furthermore, we have demonstrated for the first time that these miRNA negatively control G1 cell cycle regulators.

p53 represses c-Myc through induction of the tumor suppressor miR-145

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis

p53 inhibits the upregulation of sirtuin 1 expression induced by c-Myc.

Inactivation of Oncogenic Camp-Specific Phosphodiesterase 4D by Mir-139-5p in Response to P53 Activation

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

The pan-cancer lncRNA MILIP links c-Myc to p53 repression

Microrna-1827 Represses MDM2 to Positively Regulate Tumor Suppressor P53 and Suppress Tumorigenesis

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

P63α Modulates C-Myc Activity Via Direct Interaction and Regulation of MM1 Protein Stability

MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1∼let-7d Via Noncanonical E-box

miR‐145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC

Noncoding RNAs Regulating p53 and c-Myc Signaling

A p53-Responsive MicroRNA Network Promotes Cancer Cell Quiescence

Ribosomal Protein S14 Negatively Regulates c-Myc Activity

Microrna-149*, A P53-Responsive Microrna, Functions As An Oncogenic Regulator In Human Melanoma

MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region.

Repression of Transcription of the P27(Kip1) Cyclin-Dependent Kinase Inhibitor Gene by C-Myc

MicroRNA-339-5p Inhibits Colorectal Tumorigenesis Through Regulation of the MDM2/p53 Signaling.

Lin-28B Transactivation is Necessary for Myc-mediated Let-7 Repression and Proliferation

microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13.

Mir-19b Promotes Tumor Growth and Metastasis Via Targeting Tp53